265 related articles for article (PubMed ID: 9326232)
1. The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin.
Peretz H; Mulai A; Usher S; Zivelin A; Segal A; Weisman Z; Mittelman M; Lupo H; Lanir N; Brenner B; Shpilberg O; Seligsohn U
Blood; 1997 Oct; 90(7):2654-9. PubMed ID: 9326232
[TBL] [Abstract][Full Text] [Related]
2. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews.
Shpilberg O; Peretz H; Zivelin A; Yatuv R; Chetrit A; Kulka T; Stern C; Weiss E; Seligsohn U
Blood; 1995 Jan; 85(2):429-32. PubMed ID: 7811996
[TBL] [Abstract][Full Text] [Related]
3. Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews.
Peretz H; Salomon O; Mor-Cohen R; Usher S; Zucker M; Zivelin A; Seligsohn U
J Thromb Haemost; 2013 Apr; 11(4):724-30. PubMed ID: 23332144
[TBL] [Abstract][Full Text] [Related]
4. Two common mutations causing factor XI deficiency in Ashkenazi Jews may point to a European origin.
Zoossmann-Diskin A
Blood; 1995 Oct; 86(8):3267-8. PubMed ID: 7579427
[No Abstract] [Full Text] [Related]
5. Molecular genetics aspects of factor XI deficiency and Glanzmann thrombasthenia.
Seligsohn U; Peretz H
Haemostasis; 1994; 24(2):81-5. PubMed ID: 7959366
[TBL] [Abstract][Full Text] [Related]
6. Age estimate of the N370S mutation causing Gaucher disease in Ashkenazi Jews and European populations: A reappraisal of haplotype data.
Colombo R
Am J Hum Genet; 2000 Feb; 66(2):692-7. PubMed ID: 10677327
[TBL] [Abstract][Full Text] [Related]
7. Age estimates of two common mutations causing factor XI deficiency: recent genetic drift is not necessary for elevated disease incidence among Ashkenazi Jews.
Goldstein DB; Reich DE; Bradman N; Usher S; Seligsohn U; Peretz H
Am J Hum Genet; 1999 Apr; 64(4):1071-5. PubMed ID: 10090892
[TBL] [Abstract][Full Text] [Related]
8. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
[TBL] [Abstract][Full Text] [Related]
9. An ancient autosomal haplotype bearing a rare achromatopsia-causing founder mutation is shared among Arab Muslims and Oriental Jews.
Zelinger L; Greenberg A; Kohl S; Banin E; Sharon D
Hum Genet; 2010 Sep; 128(3):261-7. PubMed ID: 20549516
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic analysis of severe coagulation factor XI deficiency in six Italian patients.
Zadra G; Asselta R; Malcovati M; Santagostino E; Peyvandi F; Mannucci PM; Tenchini ML; Duga S
Haematologica; 2004 Nov; 89(11):1332-40. PubMed ID: 15531455
[TBL] [Abstract][Full Text] [Related]
11. Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel.
Kerem E; Kalman YM; Yahav Y; Shoshani T; Abeliovich D; Szeinberg A; Rivlin J; Blau H; Tal A; Ben-Tur L
Hum Genet; 1995 Aug; 96(2):193-7. PubMed ID: 7635469
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous genotyping of coagulation factor XI type II and type III mutations by multiplex real-time polymerase chain reaction to determine their prevalence in healthy and factor XI-deficient Italians.
Zadra G; Asselta R; Tenchini ML; Castaman G; Seligsohn U; Mannucci PM; Duga S
Haematologica; 2008 May; 93(5):715-21. PubMed ID: 18387979
[TBL] [Abstract][Full Text] [Related]
13. Mutation spectrum in Jewish cystic fibrosis patients in Israel: implication to carrier screening.
Quint A; Lerer I; Sagi M; Abeliovich D
Am J Med Genet A; 2005 Jul; 136(3):246-8. PubMed ID: 15948195
[TBL] [Abstract][Full Text] [Related]
14. Frequency of LCT-13910C/T and LCT-22018G/A single nucleotide polymorphisms associated with adult-type hypolactasia/lactase persistence among Israelis of different ethnic groups.
Raz M; Sharon Y; Yerushalmi B; Birk R
Gene; 2013 Apr; 519(1):67-70. PubMed ID: 23415628
[TBL] [Abstract][Full Text] [Related]
15. Factor XI deficiency in Ashkenazi Jews in Israel.
Asakai R; Chung DW; Davie EW; Seligsohn U
N Engl J Med; 1991 Jul; 325(3):153-8. PubMed ID: 2052060
[TBL] [Abstract][Full Text] [Related]
16. A novel mutation in the HEXA gene specific to Tay-Sachs disease carriers of Jewish Iraqi origin.
Karpati M; Peleg L; Gazit E; Akstein E; Goldman B
Clin Genet; 2000 May; 57(5):398-400. PubMed ID: 10852376
[TBL] [Abstract][Full Text] [Related]
17. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population.
Aksentijevich I; Torosyan Y; Samuels J; Centola M; Pras E; Chae JJ; Oddoux C; Wood G; Azzaro MP; Palumbo G; Giustolisi R; Pras M; Ostrer H; Kastner DL
Am J Hum Genet; 1999 Apr; 64(4):949-62. PubMed ID: 10090880
[TBL] [Abstract][Full Text] [Related]
18. Familial Mediterranean fever: prevalence, penetrance and genetic drift.
Gershoni-Baruch R; Shinawi M; Leah K; Badarnah K; Brik R
Eur J Hum Genet; 2001 Aug; 9(8):634-7. PubMed ID: 11528510
[TBL] [Abstract][Full Text] [Related]
19. A molecular genetic study of factor XI deficiency.
Hancock JF; Wieland K; Pugh RE; Martinowitz U; Schulman S; Kakkar VV; Kernoff PB; Cooper DN
Blood; 1991 May; 77(9):1942-8. PubMed ID: 2018835
[TBL] [Abstract][Full Text] [Related]
20. Different effects of apolipoprotein A5 SNPs and haplotypes on triglyceride concentration in three ethnic origins.
Ken-Dror G; Goldbourt U; Dankner R
J Hum Genet; 2010 May; 55(5):300-7. PubMed ID: 20395964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
